×
About 8,288 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  2,132 results

Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis ...
https://doi.org/10.1093/ndt/gfac206
Nephrology, Dialysis, Transplantation : Official Publicat... Ketteler M, Wiecek A et. al.

Jun 26th, 2022 - We previously reported that modified-release nicotinamide (NAMR) was superior to placebo in reducing serum phosphate concentrations over 12 weeks in a large cohort of haemodialysis patients with hyperphosphataemia. Here, we report outcomes after 5...

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Coliti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211104
Drug Design, Development and Therapy; Napolitano M, D'Amico F et. al.

Jun 25th, 2022 - Upadacitinib is a selective small molecule that inhibits Janus kinase (JAK) type 1. This molecule is administrated orally and is currently approved for the treatment of rheumatoid arthritis, atopic dermatitis, and psoriatic arthritis. Upadacitinib...

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Jun 24th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulce...
https://doi.org/10.1111/jgh.15923
Journal of Gastroenterology and Hepatology; Matsuoka K, Hisamatsu T et. al.

Jun 24th, 2022 - Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We present safety and efficacy data from patients from East Asia (Japan, Korea, and Taiwan) in OCTAVE Open, an open-label, long-term extens...

see more →

Guidelines  5 results

Management of herpesvirus reactivations in patients with solid tumours and hematologic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810475
Annals of Hematology; Henze L, Buhl C et. al.

Jan 8th, 2022 - Clinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with intensive chemotherapy ...

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by...
https://doi.org/10.1111/jdv.13957
Journal of the European Academy of Dermatology and Venere... Werner RN, Nikkels AF et. al.

Nov 3rd, 2016 - Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration...

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
https://www.ncbi.nlm.nih.gov/pubmed/18528318
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

see more →

Drugs  529 results see all →

Clinicaltrials.gov  154 results

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Jun 24th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

Prevention of Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block in the ED
https://clinicaltrials.gov/ct2/show/NCT04530162

Jun 16th, 2022 - Study Objectives The goal of this study is to evaluate the rate of PHN development in emergency department patients who receive ultrasound guided nerve blocks using bupivacaine and dexamethasone for acute herpes zoster. The investigators will also...

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
https://clinicaltrials.gov/ct2/show/NCT03604406

May 31st, 2022 - Recently, a live-attenuated vaccine (Zostavax®, Merck) to prevent herpes zoster (HZ) has been developed and approved for use among individuals age 50 years or older, regardless of previous HZ or varicella history. In a pivotal study of 38,456 olde...

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)
https://clinicaltrials.gov/ct2/show/NCT05082688

May 20th, 2022 - Rationale: Vaccination of the older adults is often advised as they are a high-risk population; however, vaccine efficacy generally decreases with age. This is mainly due to a decrease in adaptive immune responses known as immunosenescence, which ...

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Su...
https://clinicaltrials.gov/ct2/show/NCT02723773

May 19th, 2022 - This is the long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine and will include a...

see more →

News  487 results

Postherpetic Pink, Smooth, Annular Convalescing Plaques
https://www.mdedge.com/dermatology/article/255657/dermatopathology/postherpetic-pink-smooth-annular-convalescing-plaques
Caroline A. Gerhardt, MD, Sarah Moore, MD et. al.

Jun 22nd, 2022 - The Diagnosis: Granuloma Annulare A biopsy of a lesion on the right flank demonstrated granulomatous inflammation and interstitial mucin (Figure), characteristic of granuloma annulare (GA). 1,2 Granuloma annulare is a relatively common skin disord.

Surprising Link Between Herpes Zoster and Dementia
https://www.medscape.com/viewarticle/975400

Jun 10th, 2022 - Herpes zoster does not appear to increase dementia risk ― on the contrary, the viral infection may offer some protection, a large population-based study suggests. "We were surprised by these results [and] the reasons for the decreased risk are unc...

RA: Risk for serious infections with leflunomide or tacrolimus vs TNFi after methotrexate failure
https://www.mdedge.com/rheumatology/article/254918/rheumatoid-arthritis/ra-risk-serious-infections-leflunomide-or

May 24th, 2022 - Key clinical point: The risks for any serious bacterial, opportunistic, or herpes zoster infections were similar with add-on leflunomide or tacrolimus and tumor necrosis factor inhibitors (TNFi) in patients with seropositive rheumatoid arthritis (.

Cutaneous Lupus Erythematosus–like Isotopic Response to Herpes Zoster Infection
https://www.mdedge.com/dermatology/article/254893/infectious-diseases/cutaneous-lupus-erythematosus-isotopic-response
Christen Botros Samaan, MD, Bethany R. Rohr, MD et. al.

May 24th, 2022 - To the Editor: Wolf isotopic response describes the development of a skin disorder at the site of another healed and unrelated skin disease. Skin disorders presenting as isotopic responses have included inflammatory, malignant, granulomatous, and.

Cupping in dermatology
https://www.mdedge.com/dermatology/article/253900/aesthetic-dermatology/cupping-dermatology
Chloe Goldman, MD

Apr 19th, 2022 - My inspiration to write about cupping this month stems from the perception that everyone seems to be talking about it, from a facialist who suggested it for me to a coworker who swears by cupping to treat her allergies. Cupping is by no means a no.

see more →

Patient Education  8 results see all →